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Introduction 
Metabolomics opens new perspectives for biomarker discovery in the field of nutrition and heath, and 
also in the development of system biology. The metabolic profiles of biofluids obtained by mass 
spectrometry or nuclear magnetic resonance contain a few hundreds to thousands of signals. 
However, a major part of this information remains unknown, or at least not characterized in the 
analytical systems, thus hampering the obtention of biologically meaningfull data. In this context, we 
here report on the development of an electrospray (ESI) spectral database for the annotation of high 
resolution mass spectrometry based metabolomics data sets and on its application to the analysis of 
urine samples from a cohort of healthy volunteers.  
 
Methods 
Urines samples were collected from 227 healthy volunteers matched according to gender (121 males, 
106 females), age (18 to 81 years-old) and body mass index. They were randomly analyzed using 
ultra performance liquid chromatography coupled to a LTQ-Orbitrap Discovery mass spectrometer 
(ThermoFisher scientifics) operated in both negative and positive ion mode with the resolution set to 
30000 (FWHM at m/z 400). Elution was performed in gradient conditions with mobile phases 
composed of water and acetonitrile containing 0.1% formic acid. Data treatment was achieved with 
XCMS R package, statistical analysis with SIMCA P11 and signals clustering with CAMERA R 
package and other home-made informatics tools, and signal annotation was performed using public 
metabolite databases and our in-house spectral database. 
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Two complementary approaches were designed to build the spectral database. The first one involved 
the analysis of mass spectra of reference compounds from our chemical library (1200 chemicals). 
Analytical information (compound related-ions recorded in both positive and negative mode and 
retention times in various chromatographic conditions) was collected from these spectra and then 
matched to that obtained from experimental metabolomics data sets. By these means, we formally 
annotated and identified about 163 metabolites (based on accurate mass, retention time and MSn 
spectral similarities to those of reference compounds) in urine samples from our cohort. The second 
approach was based on the characterization of new metabolites from experimental datasets. 
Automatic detection of ions was performed from raw data using XCMS software. Signals of interest 
were highlighted by multivariate analysis. The redundant information (i.e., isotope, in source product 
and adduct ions generated during the ionization process together with protonated or deprotonated 
ions) was then highlighted and further grouped by using mathematical and informatics tools. Finally, 
ions of interest were annotated thanks to queries of metabolomic public databases with the measured 
accurate masses and characterized by MSn experiments. By these means, 81 metabolites were 
putatively identified, based on accurate mass and interpretation of MSnspectra, Altogether 244 
metabolites were identified or putatively identified including 78 never described in Human urines yet. 
139 were only characterized by matching of the accurate measured mass to that of metabolites 
present in public databases, and the interpretation of their MSn spectra is under progress. In fact 
these 383 metabolites represent 1000 ions in both positive and negative ion mode. At last, we also 
address the impact of physiological factors such as gender, age and body mass index on the urinary 
concentrations of two hundred compounds for further building of a database of metabolic profiles. 
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• Statistical analysis
• Peak grouping
• Database annotation 
(HMDB, KEGG, Metlin…)
•MSn
Metabolomics relational
database: 
- Kind of biofluid
- Physiological Factors
- Disease, toxicology
• m/z of molecular ions (adducts, 
isotopes, in-source fragments)
• Retention time(s)
• MSn
